268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading
The Readout Loud
00:00
Eli Lilly's GLP1 Plus Medicine for Obesity and Diabetes
New data on Terzepa Tide, which is Eli Lilly's GLP1 Plus medicine marketed as Mount Jaro. People who stayed on the drug lost an additional 6.7% of their body weight over the next year. People who came off the drug on average regained 15% oftheir body weight.
Transcript
Play full episode
